NEW YORK (GenomeWeb) – Thermo Fisher Scientific has issued $1 billion in aggregate principal amount of 3 percent senior notes due April 15, 2023, according to a document filed Wednesday with the US Securities and Exchange Commission.
The Waltham, Massachusetts-based company announced its intent to offer the dollar-denominated notes earlier this month. The firm plans to use the proceeds to redeem $1 billion in outstanding 2.25 percent senior notes that mature August 15. Thermo said in its Form 8-K that the outstanding notes would be redeemed on April 19.
The joint book-running managers for the offering are Merrill Lynch; Pierce, Fenner & Smith; Goldman Sachs; and Morgan Stanley.